It has been shown that the decreased expression of m6A methylase (METTL3, METTL14, and WTAP) and the increased expression of m6A methylase (FTO and ALKBH5) in breast cancer are closely related to the progression and poor survival rate of breast cancer [28]. This evidence concerns the gene FTO and breast carcinoma.